a year ago
OBSVF
AnalystsRaghuram SelvarajuRaghuram Selvaraju's Stock Forecasts
AnalystsRaghuram Selvaraju
Analyst Ranking
Bottom 1%
#4412 out of 4414 analysts
Average Return
-8.81%
Win Rate
30%163 out of 540
Risk vs Reward
Poor
Good
Raghuram Selvaraju's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +713.02% | $6.91 | $56.18 | 2022-07-20 - 2023-07-20 | Buy |
Cormedix IncCRMD | +677.78% | $0.90 | $7.00 | 2018-05-22 - 2019-05-23 | Buy |
Anavex Life Sciences CorpAVXL | +547.79% | $2.49 | $16.13 | 2020-03-15 - 2021-03-16 | Buy |
Provention Bio IncPRVB | +452.19% | $4.33 | $23.91 | 2022-07-10 - 2023-03-15 | Buy |
Biolife Solutions IncBLFS | +380.32% | $8.74 | $41.98 | 2020-03-22 - 2021-03-23 | Buy |
Raghuram Selvaraju Analyst Color
Get additional color on Raghuram Selvaraju's coverage of popular stocks
Raghuram Selvaraju's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Genmab AGMAB | 22 | Buy | $49.00 | +56.65% | Reiterates | 3 days ago |
Annovis Bio IncANVS | 8 | Buy | $30.00 | +261.01% | Reiterates | 3 days ago |
Anavex Life Sciences CorpAVXL | 12 | Buy | $54.00 | +661.64% | Reiterates | 3 days ago |
Entrada Therapeutics IncTRDA | 6 | Buy | $20.00 | +53.61% | Maintains | 4 days ago |
Kezar Life Sciences IncKZR | 9 | Buy | $20.00 | +2,306.74% | Reiterates | 4 days ago |
Moonlake ImmunotherapeuticsMLTX | 14 | Buy | $75.00 | +77.35% | Reiterates | 4 days ago |
Spruce Biosciences IncSPRB | 7 | Buy | $10.00 | +629.93% | Reiterates | 11 days ago |
Karuna Therapeutics IncKRTX | 12 | Buy | $300.00 | +59.08% | Reiterates | 11 days ago |
Adma Biologics IncADMA | 9 | Buy | $5.00 | +34.05% | Reiterates | 14 days ago |
Rockwell Medical IncRMTI | 15 | Buy | $11.00 | +488.24% | Reiterates | 16 days ago |
Rapt Therapeutics IncRAPT | 14 | Buy | $41.00 | +172.97% | Reiterates | 16 days ago |
Bioxcel Therapeutics IncBTAI | 27 | Buy | $11.00 | +182.05% | Reiterates | 16 days ago |
Aclaris Therapeutics IncACRS | 9 | Buy | $9.00 | +925.06% | Maintains | 17 days ago |
Protalix Biotherapeutics IncPLX | 5 | Buy | $10.00 | +599.30% | Reiterates | 17 days ago |
Spero Therapeutics IncSPRO | 11 | Buy | $7.00 | +498.29% | Reiterates | 17 days ago |
Sol Gel Technologies LtdSLGL | 13 | Buy | $9.00 | +620.00% | Maintains | 18 days ago |
Equillium IncEQ | 6 | Buy | $4.50 | +768.73% | Maintains | 18 days ago |
Aeterna Zentaris IncAEZS | 10 | Buy | $15.00 | +653.77% | Maintains | 18 days ago |
Aquestive Therapeutics IncAQST | 10 | Buy | $6.00 | +175.23% | Maintains | 23 days ago |
Reviva Pharmaceuticals Holdings IncRVPH | 7 | Buy | $20.00 | +405.05% | Maintains | a month ago |
Balchem CorpBCPC | 10 | Buy | $135.00 | +8.05% | Maintains | a month ago |
Microbot Medical IncMBOT | 4 | Buy | $8.00 | +534.92% | Reiterates | a month ago |
Polypid LtdPYPD | 1 | Buy | $16.00 | +249.34% | Initiates Coverage On | 2 months ago |
Scilex Holding CoSCLX | 1 | Buy | $12.00 | +757.14% | Initiates Coverage On | 2 months ago |
Cocrystal Pharma IncCOCP | 8 | Buy | $12.00 | +548.65% | Reiterates | 2 months ago |
Urogen Pharma LtdURGN | 13 | Buy | $54.00 | +320.56% | Reiterates | 2 months ago |
Cingulate IncCING | 2 | Buy | $70.00 | +22,480.65% | Maintains | 2 months ago |
Enlivex Therapeutics LtdENLV | 7 | Buy | $12.00 | +541.71% | Maintains | 2 months ago |
Ensysce Biosciences IncENSC | 2 | Buy | $7.00 | +759.95% | Maintains | 2 months ago |
Anebulo Pharmaceuticals IncANEB | 2 | Buy | $6.00 | +179.07% | Reiterates | 2 months ago |
Brainsway LtdBWAY | 12 | Buy | $12.00 | +86.34% | Reiterates | 2 months ago |
Regulus Therapeutics IncRGLS | 7 | Buy | $9.00 | +597.67% | Reiterates | 2 months ago |
Indaptus Therapeutics IncINDP | 9 | Buy | $12.00 | +466.04% | Reiterates | 2 months ago |
Gain Therapeutics IncGANX | 7 | Buy | $10.00 | +348.43% | Reiterates | 2 months ago |
Oncternal Therapeutics IncONCT | 4 | Buy | $2.00 | +455.56% | Upgrades | 2 months ago |
Entera Bio LtdENTX | 6 | Buy | $10.00 | +1,330.62% | Reiterates | 3 months ago |
Verona Pharma PLCVRNA | 9 | Buy | $32.00 | +144.27% | Reiterates | 3 months ago |
Arcadia Biosciences IncRKDA | 10 | Buy | $10.00 | +277.36% | Maintains | 3 months ago |
Galecto IncGLTO | 4 | Buy | $2.00 | +236.13% | Maintains | 3 months ago |
Cartesian Therapeutics IncRNAC | 5 | Buy | $5.00 | +346.43% | Reiterates | 3 months ago |
Galera Therapeutics IncGRTX | 6 | Hold | $0.30 | +117.39% | Downgrades | 3 months ago |
Cardiff Oncology IncCRDF | 10 | Buy | $12.00 | +891.74% | Maintains | 4 months ago |
Eton Pharmaceuticals IncETON | 8 | Buy | $10.00 | +172.48% | Maintains | 4 months ago |
Chromadex CorpCDXC | 10 | Buy | $5.00 | +275.94% | Reiterates | 4 months ago |
Axsome Therapeutics IncAXSM | 12 | Buy | $180.00 | +169.26% | Maintains | 4 months ago |
Fennec Pharmaceuticals IncFENC | 7 | Buy | $17.00 | +97.22% | Maintains | 4 months ago |
Fate Therapeutics IncFATE | 1 | Hold | $7.00 | +167.18% | Reiterates | 7 months ago |
Provention Bio IncPRVB | 6 | Hold | $25.00 | +0.08% | Downgrades | 9 months ago |
Tourmaline Bio IncTRML | 3 | Buy | $12.00 | -34.85% | Reiterates | 10 months ago |
Taro Pharmaceutical Industries LtdTARO | 7 | Buy | $35.00 | -5.05% | Maintains | 10 months ago |
Timber Pharmaceuticals IncTMBR | 4 | Buy | $50.00 | N/A | Maintains | a year ago |
Obseva SaOBSVF | 6 | Hold | N/A | N/A | Downgrades | a year ago |
Aptinyx IncAPTX | 2 | Buy | $1.00 | N/A | Maintains | a year ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Buy | $4.50 | N/A | Maintains | a year ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $12.00 | N/A | Maintains | a year ago |
Evofem Biosciences IncEVFM | 8 | Buy | $4.00 | N/A | Maintains | a year ago |
Elicio Therapeutics IncELTX | 5 | Hold | N/A | N/A | Downgrades | a year ago |
Addex Therapeutics LtdADXN | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Tyra Biosciences IncTYRA | 1 | Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Neubase Therapeutics IncNBSE | 4 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Sorrento Therapeutics IncSRNEQ | 4 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Bridgebio Pharma IncBBIO | 3 | Buy | $24.00 | N/A | Maintains | 2 years ago |
Oramed Pharmaceuticals IncORMP | 2 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Inmed Pharmaceuticals IncINM | 1 | Buy | $150.00 | N/A | Initiates Coverage On | 2 years ago |
Abeona Therapeutics IncABEO | 5 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Gri Bio IncGRI | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Omeros CorpOMER | 4 | Buy | $12.00 | N/A | Maintains | 2 years ago |
Landos Biopharma IncLABP | 1 | Buy | $500.00 | N/A | Initiates Coverage On | 2 years ago |
Synlogic IncSYBX | 3 | Buy | $105.00 | N/A | Maintains | 2 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $9.10 | N/A | Downgrades | 2 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $840.00 | N/A | Maintains | 2 years ago |
Itamar Medical LtdITMR | 3 | Hold | $31.00 | N/A | Downgrades | 2 years ago |
Immunic IncIMUX | 3 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Acorda Therapeutics IncACOR | 4 | Buy | $200.00 | N/A | Upgrades | 2 years ago |
Exicure IncXCUR | 2 | Buy | $180.00 | N/A | Maintains | 3 years ago |
Repligen CorpRGEN | 5 | Buy | $240.00 | N/A | Maintains | 3 years ago |
Bausch Health Companies IncBHC | 4 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Tff Pharmaceuticals IncTFFP | 2 | Buy | $37.00 | N/A | Maintains | 3 years ago |
Viela Bio IncVIE | 2 | Hold | $53.00 | N/A | Downgrades | 3 years ago |
Neurobo Pharmaceuticals IncNRBO | 2 | Buy | $480.00 | N/A | Maintains | 3 years ago |
Zosano Pharma CorpZSANQ | 2 | Buy | $2.50 | N/A | Maintains | 3 years ago |
Caredx IncCDNA | 3 | Buy | $40.00 | N/A | Maintains | 3 years ago |
Meridian Bioscience IncVIVO | 1 | Buy | $34.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Dna Sciences IncAPDN | 2 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Biospecifics Technologies CorpBSTC | 2 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Cytodyn IncCYDY | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Replimune Group IncREPL | 1 | Hold | $25.00 | N/A | Downgrades | 3 years ago |
Igm Biosciences IncIGMS | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 3 years ago |
Evoke Pharma IncEVOK | 2 | Buy | $120.00 | N/A | Upgrades | 3 years ago |
Biolife Solutions IncBLFS | 1 | Buy | $17.00 | N/A | Maintains | 4 years ago |
Springworks Therapeutics IncSWTX | 1 | Buy | $60.00 | N/A | Upgrades | 4 years ago |
Stemline Therapeutics IncSTML | 1 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Kala Bio IncKALA | 3 | Buy | $600.00 | N/A | Reiterates | 4 years ago |
First Wave Biopharma IncFWBI | 2 | Buy | $7.00 | N/A | Maintains | 5 years ago |
Celcuity IncCELC | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 5 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $32.00 | N/A | Initiates Coverage On | 5 years ago |
Cormedix IncCRMD | 2 | Buy | $10.00 | N/A | Maintains | 6 years ago |
Ladrx CorpLADX | 1 | Buy | $4.50 | N/A | Maintains | 6 years ago |
Check Cap LtdCHEK | 1 | Buy | $280.00 | N/A | Maintains | 6 years ago |
Oncosec Medical IncONCSQ | 2 | Buy | $880.00 | N/A | Maintains | 6 years ago |
T2 Biosystems IncTTOO | 2 | Buy | $42,500.00 | N/A | Maintains | 6 years ago |
Lisata Therapeutics IncLSTA | 1 | Buy | $12.00 | N/A | Maintains | 6 years ago |
Durect CorpDRRX | 2 | Buy | $35.00 | N/A | Upgrades | 6 years ago |
Dentsply Sirona IncXRAY | 3 | Hold | $63.00 | N/A | Maintains | 6 years ago |
Aethlon Medical IncAEMD | 1 | Buy | $450.00 | N/A | Initiates Coverage On | 6 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Buy | $5.00 | N/A | Maintains | 6 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $300.00 | N/A | Maintains | 6 years ago |
Immuron LtdIMRN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 6 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 6 years ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 6 years ago |
Alimera Sciences IncALIM | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.